Actionable news
0
All posts from Actionable news
Actionable news in CTIC: Cell Therapeutics, Inc.,

Cell Therapeutics just filed a prospectus, suggesting it plans to soon issue some securities

Cell Therapeutics just came out with a new prospectus, available here. This is an SEC requirement for firms looking to issue certain types of securities. An excerpt of the prospectus is provided below:

FWP 1 d18491dfwp.htm FREE WRITING PROSPECTUS Free Writing Prospectus Issuer Free Writing Prospectus dated October 27, 2015 Filed Pursuant to Rule 433 Registration No. 333-200452 (Relating to the Preliminary Prospectus Supplement dated October 26, 2015 and the Prospectus dated December 8, 2014) 50,000 Shares of Series N-1 Preferred Stock Issuer: CTI BioPharma Corp. Symbol: CTIC Shares offered: 50,000 shares of Series N-1 Preferred Stock (convertibl e into 40.0 million shares of common stock at the initial conversion price) Price per share to the public: $1,000 Initial...


More